Amedeo Smart

Free Medical Literature Service


 

Amedeo

Vaccines

  Free Subscription

Articles published in
Science
    September 2021
  1. MATEUS J, Dan JM, Zhang Z, Rydyznski Moderbacher C, et al
    Low-dose mRNA-1273 COVID-19 vaccine generates durable memory enhanced by cross-reactive T cells.
    Science. 2021 Sep 14:eabj9853. doi: 10.1126/science.abj9853.
    >> Share

    August 2021
  2. LOYAL L, Braun J, Henze L, Kruse B, et al
    Cross-reactive CD4(+) T cells enhance SARS-CoV-2 immune responses upon infection and vaccination.
    Science. 2021 Aug 31. pii: science.abh1823. doi: 10.1126/science.abh1823.
    >> Share

  3. MCROBBIE MA
    Colleges must require vaccination.
    Science. 2021;373:945.
    >> Share

  4. COHEN J
    Antibody acts like short-term malaria vaccine.
    Science. 2021;373:843.
    >> Share

  5. KUPFERSCHMIDT K
    Evolving threat.
    Science. 2021;373:844-849.
    >> Share

  6. WADMAN M
    Israel's grim warning: Delta can overwhelm shots.
    Science. 2021;373:838-839.
    >> Share

  7. WAGNER CE, Saad-Roy CM, Morris SE, Baker RE, et al
    Vaccine nationalism and the dynamics and control of SARS-CoV-2.
    Science. 2021 Aug 17. pii: science.abj7364. doi: 10.1126/science.abj7364.
    >> Share

  8. FAUSTHER-BOVENDO H, Kobinger G
    Plant-made vaccines and therapeutics.
    Science. 2021;373:740-741.
    >> Share

  9. PEGU A, O'Connell S, Schmidt SD, O'Dell S, et al
    Durability of mRNA-1273 vaccine-induced antibodies against SARS-CoV-2 variants.
    Science. 2021 Aug 12. pii: science.abj4176. doi: 10.1126/science.abj4176.
    >> Share

  10. OZA A
    Studies probe how payouts affect U.S. vaccination rates.
    Science. 2021;373:611.
    >> Share

    July 2021
  11. WADMAN M
    The overlooked superpower of mRNA vaccines.
    Science. 2021;373:479.
    >> Share

  12. LUND FE, Randall TD
    Scent of a vaccine.
    Science. 2021;373:397-399.
    >> Share

  13. THORP HH
    Colleges need vaccine mandates.
    Science. 2021;373:369.
    >> Share

  14. WADMAN M
    Journal retracts paper claiming COVID-19 vaccines kill.
    Science. 2021;373:147.
    >> Share

  15. COHEN J
    Can immune responses predict which vaccines work best?
    Science. 2021;373:142-143.
    >> Share

  16. O'GRADY C
    Sex and gender missing in COVID-19 data.
    Science. 2021;373:145.
    >> Share

  17. MCCALLUM M, Bassi J, De Marco A, Chen A, et al
    SARS-CoV-2 immune evasion by the B.1.427/B.1.429 variant of concern.
    Science. 2021 Jul 1. pii: science.abi7994. doi: 10.1126/science.abi7994.
    >> Share

    June 2021
  18. MARTINEZ DR, Schafer A, Leist SR, De la Cruz G, et al
    Chimeric spike mRNA vaccines protect against Sarbecovirus challenge in mice.
    Science. 2021 Jun 22. pii: science.abi4506. doi: 10.1126/science.abi4506.
    >> Share

  19. VOGEL G
    Mixing vaccines may boost immune responses.
    Science. 2021;372:1138.
    >> Share

  20. COHEN J
    'Landmark' African vaccine trial faces impasse.
    Science. 2021;372:1135-1136.
    >> Share

    May 2021
  21. BALICER RD, Ohana R
    Israel's COVID-19 endgame.
    Science. 2021;372:663.
    >> Share

  22. KARRON RA
    Preventing respiratory syncytial virus (RSV) disease in children.
    Science. 2021;372:686-687.
    >> Share

  23. MOUTINHO S, Wadman M
    Brazil and Russia face off over vaccine contamination charge.
    Science. 2021;372:554.
    >> Share

    April 2021
  24. REYNOLDS CJ, Pade C, Gibbons JM, Butler DK, et al
    Prior SARS-CoV-2 infection rescues B and T cell responses to variants after first vaccine dose.
    Science. 2021 Apr 30. pii: science.abh1282. doi: 10.1126/science.abh1282.
    >> Share

  25. WADMAN M
    Malaria vaccine achieves striking early success.
    Science. 2021;372:448.
    >> Share

  26. COUZIN-FRANKEL J
    Relief and worry for immune-suppressed people.
    Science. 2021;372:443-444.
    >> Share

  27. RABESANDRATANA T
    After vaccine failures, France laments biomedical decline.
    Science. 2021;372:331-332.
    >> Share

  28. HANAGE WP, Russell CA
    Partial immunity and SARS-CoV-2 mutations.
    Science. 2021;372:354.
    >> Share

  29. COHEN J
    The dream vaccine.
    Science. 2021;372:227-231.
    >> Share

  30. KUPFERSCHMIDT K, Vogel G
    Vaccine link to serious clotting disorder firms up.
    Science. 2021;372:220-221.
    >> Share

  31. DOBROVIDOVA O
    Latest Russian vaccine comes with a big dose of mystery.
    Science. 2021;372:116-117.
    >> Share

  32. FAUCI AS
    The story behind COVID-19 vaccines.
    Science. 2021;372:109.
    >> Share

  33. VOGEL G, Kupferschmidt K
    Side effect worry grows for AstraZeneca vaccine.
    Science. 2021;372:14-15.
    >> Share

  34. CHANDRASHEKHAR V
    India speeds up vaccinations as cases soar again.
    Science. 2021;372:12-13.
    >> Share

    March 2021
  35. VOGEL G, Kupferschmidt K
    New problems erode confidence in AstraZeneca's vaccine.
    Science. 2021;371:1294-1295.
    >> Share

  36. LARSON HJ, Broniatowski DA
    Volatility of vaccine confidence.
    Science. 2021;371:1289.
    >> Share

  37. MCCORMICK KD, Jacobs JL, Mellors JW
    The emerging plasticity of SARS-CoV-2.
    Science. 2021;371:1306-1308.
    >> Share

  38. LESTE-LASSERRE C
    Deadly viral outbreak ravages European horses.
    Science. 2021;371:1297.
    >> Share

  39. STAMATATOS L, Czartoski J, Wan YH, Homad LJ, et al
    mRNA vaccination boosts cross-variant neutralizing antibodies elicited by SARS-CoV-2 infection.
    Science. 2021 Mar 25. pii: science.abg9175. doi: 10.1126/science.abg9175.
    >> Share

  40. VERWEIJ M, Hansen SG, Iyer R, John N, et al
    Modulation of MHC-E transport by viral decoy ligands is required for RhCMV/SIV vaccine efficacy.
    Science. 2021 Mar 25. pii: science.abe9233. doi: 10.1126/science.abe9233.
    >> Share

  41. DYE C, Mills MC
    COVID-19 vaccination passports.
    Science. 2021;371:1184.
    >> Share

  42. LUCHSINGER LL, Hillyer CD
    Vaccine efficacy probable against COVID-19 variants.
    Science. 2021;371:1116.
    >> Share

  43. COHEN J, Kupferschmidt K
    As vaccine surpluses loom, donation plans urged.
    Science. 2021;371:1087-1088.
    >> Share

  44. ALTMANN DM, Boyton RJ, Beale R
    Immunity to SARS-CoV-2 variants of concern.
    Science. 2021;371:1103-1104.
    >> Share

  45. SAAD-ROY CM, Morris SE, Metcalf CJE, Mina MJ, et al
    Epidemiological and evolutionary considerations of SARS-CoV-2 vaccine dosing regimes.
    Science. 2021 Mar 9. pii: science.abg8663. doi: 10.1126/science.abg8663.
    >> Share

  46. DAVIES NG, Abbott S, Barnard RC, Jarvis CI, et al
    Estimated transmissibility and impact of SARS-CoV-2 lineage B.1.1.7 in England.
    Science. 2021 Mar 3. pii: science.abg3055. doi: 10.1126/science.abg3055.
    >> Share

    February 2021
  47. COUZIN-FRANKEL J
    Vaccine trials ramp up in children and adolescents.
    Science. 2021;371:874-875.
    >> Share

  48. CASTILLO JC, Ahuja A, Athey S, Baker A, et al
    Market design to accelerate COVID-19 vaccine supply.
    Science. 2021 Feb 25. pii: science.abg0889. doi: 10.1126/science.abg0889.
    >> Share

  49. KUPFERSCHMIDT K
    Deaths of health workers in Africa highlight vaccine inequity.
    Science. 2021;371:764-765.
    >> Share

  50. CASASSUS B
    France turns to citizens' panel to reduce vaccine skepticism.
    Science. 2021;371:763-764.
    >> Share

  51. KOFF WC, Berkley SF
    A universal coronavirus vaccine.
    Science. 2021;371:759.
    >> Share

  52. COHEN J
    The long road.
    Science. 2021;371:768-772.
    >> Share

  53. COHEN J
    Two new vaccines deliver good and bad news for the pandemic.
    Science. 2021;371:548-549.
    >> Share

  54. MONOD M, Blenkinsop A, Xi X, Hebert D, et al
    Age groups that sustain resurging COVID-19 epidemics in the United States.
    Science. 2021 Feb 2. pii: science.abe8372. doi: 10.1126/science.abe8372.
    >> Share

    January 2021
  55. MUIK A, Wallisch AK, Sanger B, Swanson KA, et al
    Neutralization of SARS-CoV-2 lineage B.1.1.7 pseudovirus by BNT162b2 vaccine-elicited human sera.
    Science. 2021 Jan 29. pii: science.abg6105. doi: 10.1126/science.abg6105.
    >> Share

  56. PROVINE NM, Amini A, Garner LC, Spencer AJ, et al
    MAIT cell activation augments adenovirus vector vaccine immunogenicity.
    Science. 2021;371:521-526.
    >> Share

  57. GALANTI M, Pei S, Yamana TK, Angulo FJ, et al
    Social distancing remains key during vaccinations.
    Science. 2021;371:473-474.
    >> Share

  58. JUNO JA, O'Connor SL
    Translating viral vaccines into immunity.
    Science. 2021;371:460-461.
    >> Share

  59. COHEN J
    Ex-vaccine chief reflects on triumphs, failures, and Trump.
    Science. 2021;371:449-450.
    >> Share

  60. KUPFERSCHMIDT K
    Vaccinemakers ponder how to adapt to virus variants.
    Science. 2021;371:448-449.
    >> Share

  61. FITZPATRICK MC, Galvani AP
    Optimizing age-specific vaccination.
    Science. 2021 Jan 21. pii: science.abg2334. doi: 10.1126/science.abg2334.
    >> Share

  62. BUBAR KM, Reinholt K, Kissler SM, Lipsitch M, et al
    Model-informed COVID-19 vaccine prioritization strategies by age and serostatus.
    Science. 2021 Jan 21. pii: science.abe6959. doi: 10.1126/science.abe6959.
    >> Share


  63. Q&A: How to market vaccination.
    Science. 2021;371:223.
    >> Share

  64. NORMILE D
    Pandemic could mark 'turning point' for Chinese science.
    Science. 2021;371:222-223.
    >> Share

  65. THORP HH
    Public debate is good for science.
    Science. 2021;371:213.
    >> Share

  66. LAVINE JS, Bjornstad ON, Antia R
    Immunological characteristics govern the transition of COVID-19 to endemicity.
    Science. 2021 Jan 12. pii: science.abe6522. doi: 10.1126/science.abe6522.
    >> Share

  67. COHEN AA, Gnanapragasam PNP, Lee YE, Hoffman PR, et al
    Mosaic nanoparticles elicit cross-reactive immune responses to zoonotic coronaviruses in mice.
    Science. 2021 Jan 12. pii: science.abf6840. doi: 10.1126/science.abf6840.
    >> Share

  68. KRIENKE C, Kolb L, Diken E, Streuber M, et al
    A noninflammatory mRNA vaccine for treatment of experimental autoimmune encephalomyelitis.
    Science. 2021;371:145-153.
    >> Share

  69. COHEN J
    Dosing debates, transparency issues roil vaccine rollouts.
    Science. 2021;371:109-110.
    >> Share

  70. DE VRIEZE J
    Pfizer's vaccine raises allergy concerns.
    Science. 2021;371:10-11.
    >> Share

    December 2020
  71. LARSEN MD, de Graaf EL, Sonneveld ME, Plomp HR, et al
    Afucosylated IgG characterizes enveloped viral responses and correlates with COVID-19 severity.
    Science. 2020 Dec 23. pii: science.abc8378. doi: 10.1126/science.abc8378.
    >> Share

  72. CAPLAN A, Bateman-House A
    Transparency is key to ethical vaccine research-Response.
    Science. 2020;370:1423-1424.
    >> Share

  73. GUERRINI CJ, Sherkow JS, Meyer MN, Zettler PJ, et al
    Transparency is key to ethical vaccine research-Response.
    Science. 2020;370:1423.
    >> Share

  74. ESTEP PW, Church GM
    Transparency is key to ethical vaccine research.
    Science. 2020;370:1422-1423.
    >> Share

  75. COHEN J, Kupferschmidt K
    As vaccines emerge, a global waiting game begins.
    Science. 2020;370:1385-1387.
    >> Share

  76. COHEN J
    Shots of hope.
    Science. 2020;370:1392-1394.
    >> Share

  77. SERVICK K
    mRNA's next challenge: Will it work as a drug?
    Science. 2020;370:1388-1389.
    >> Share

  78. COHEN J
    China's vaccine gambit.
    Science. 2020;370:1263-1267.
    >> Share

  79. THORP HH
    An opportunity to improve innovation.
    Science. 2020;370:1251.
    >> Share

  80. COHEN J
    Amid the cheering, some vaccines face questions.
    Science. 2020;370:1151.
    >> Share

  81. CORNWALL W
    New challenges emerge for planned human challenge trials.
    Science. 2020;370:1150.
    >> Share

  82. WENDLER D, Ochoa J, Millum J, Grady C, et al
    COVID-19 vaccine trial ethics once we have efficacious vaccines.
    Science. 2020 Dec 3. pii: science.abf5084. doi: 10.1126/science.abf5084.
    >> Share

    November 2020
  83. WADMAN M
    Public needs to prep for vaccine side effects.
    Science. 2020;370:1022.
    >> Share

  84. COHEN J
    Vaccine wagers on coronavirus surface protein pay off.
    Science. 2020;370:894-895.
    >> Share

  85. GUPTA R
    Advancing new tools for infectious diseases.
    Science. 2020;370:913-914.
    >> Share

  86. KNIPE DM, Levy O, Fitzgerald KA, Muhlberger E, et al
    Ensuring vaccine safety.
    Science. 2020 Nov 17. pii: science.abf0357. doi: 10.1126/science.abf0357.
    >> Share

  87. ROBERTS L
    New polio vaccine could boost faltering eradication drive.
    Science. 2020;370:751-752.
    >> Share

  88. COHEN J
    Effective vaccine offers shot of hope for pandemic.
    Science. 2020;370:748-749.
    >> Share

  89. WADMAN M
    'Nothing is impossible,' says lab ace Nita Patel.
    Science. 2020;370:652.
    >> Share

  90. WADMAN M
    The long shot.
    Science. 2020;370:649-653.
    >> Share

    October 2020
  91. COHEN J
    First vaccine may stymie hunt for better ones.
    Science. 2020;370:389-390.
    >> Share

  92. LIPSITCH M, Dean NE
    Understanding COVID-19 vaccine efficacy.
    Science. 2020 Oct 21. pii: science.abe5938. doi: 10.1126/science.abe5938.
    >> Share

  93. BANGARU S, Ozorowski G, Turner HL, Antanasijevic A, et al
    Structural analysis of full-length SARS-CoV-2 spike protein from an advanced vaccine candidate.
    Science. 2020 Oct 20. pii: science.abe1502. doi: 10.1126/science.abe1502.
    >> Share

  94. THORP HH
    Not throwing away our shot.
    Science. 2020;370:266.
    >> Share

  95. COHEN J
    A call to test new vaccines head to head, in monkeys.
    Science. 2020;370:154-155.
    >> Share

    September 2020
  96. GUERRINI CJ, Sherkow JS, Meyer MN, Zettler PJ, et al
    Self-experimentation, ethics, and regulation of vaccines.
    Science. 2020;369:1570-1572.
    >> Share

  97. KUPFERSCHMIDT K
    Despite obstacles, WHO unveils plan to distribute vaccine.
    Science. 2020;369:1553.
    >> Share

  98. SAAD-ROY CM, Wagner CE, Baker RE, Morris SE, et al
    Immune life history, vaccination, and the dynamics of SARS-CoV-2 over the next 5 years.
    Science. 2020 Sep 21. pii: science.abd7343. doi: 10.1126/science.abd7343.
    >> Share


  99. Erratum for the Report "Generation of influenza A viruses as live but replication-incompetent virus vaccines" by L. Si, H. Xu, X. Zhou, Z. Zhang, Z. Tian, Y. Wang, Y. Wu, B. Zhang, Z. Niu, C. Zhang, G. Fu, S. Xiao, Q. Xia, L. Zhang, D. Zhou.
    Science. 2020;369.
    >> Share

  100. EMANUEL EJ, Persad G, Kern A, Buchanan A, et al
    An ethical framework for global vaccine allocation.
    Science. 2020 Sep 3. pii: science.abe2803. doi: 10.1126/science.abe2803.
    >> Share

    August 2020
  101. CAPLAN AL, Bateman-House A
    The danger of DIY vaccines.
    Science. 2020;369:1035.
    >> Share

  102. KATZELNICK LC, Narvaez C, Arguello S, Lopez Mercado B, et al
    Zika virus infection enhances future risk of severe dengue disease.
    Science. 2020;369:1123-1128.
    >> Share

  103. COHEN J
    Antibodies may curb pandemic before vaccines.
    Science. 2020;369:752-753.
    >> Share

  104. FIDLER DP
    Vaccine nationalism's politics.
    Science. 2020;369:749.
    >> Share

  105. THORP HH
    A dangerous rush for vaccines.
    Science. 2020 Aug 13. pii: science.abe3147. doi: 10.1126/science.abe3147.
    >> Share

  106. DAVIS CW, Jackson KJL, McCausland MM, Darce J, et al
    Influenza vaccine-induced human bone marrow plasma cells decline within a year after vaccination.
    Science. 2020 Aug 13. pii: science.aaz8432. doi: 10.1126/science.aaz8432.
    >> Share

  107. PRICE WN 2ND, Rai AK, Minssen T
    Knowledge transfer for large-scale vaccine manufacturing.
    Science. 2020 Aug 13. pii: science.abc9588. doi: 10.1126/science.abc9588.
    >> Share

    July 2020
  108. KUPFERSCHMIDT K
    Global plan seeks to promote vaccine equity, spread risks.
    Science. 2020;369:489-490.
    >> Share

  109. THORP HH
    Cautious optimism.
    Science. 2020;369:483.
    >> Share

  110. GU H, Chen Q, Yang G, He L, et al
    Adaptation of SARS-CoV-2 in BALB/c mice for testing vaccine efficacy.
    Science. 2020 Jul 30. pii: science.abc4730. doi: 10.1126/science.abc4730.
    >> Share

  111. ROBERTS L
    Polio vaccinators are back after pandemic pause.
    Science. 2020;369:360.
    >> Share

  112. HSIEH CL, Goldsmith JA, Schaub JM, DiVenere AM, et al
    Structure-based design of prefusion-stabilized SARS-CoV-2 spikes.
    Science. 2020 Jul 23. pii: science.abd0826. doi: 10.1126/science.abd0826.
    >> Share

  113. GUHA-SAPIR D, Moitinho de Almeida M, Keita M, Greenough G, et al
    COVID-19 policies: Remember measles.
    Science. 2020;369:261.
    >> Share

  114. YUAN M, Liu H, Wu NC, Lee CD, et al
    Structural basis of a shared antibody response to SARS-CoV-2.
    Science. 2020 Jul 13. pii: science.abd2321. doi: 10.1126/science.abd2321.
    >> Share

  115. SHAH SK, Miller FG, Darton TC, Duenas D, et al
    Unnecessary hesitancy on human vaccine tests-Response.
    Science. 2020;369:151.
    >> Share

  116. EYAL N
    Unnecessary hesitancy on human vaccine tests.
    Science. 2020;369:150-151.
    >> Share

  117. COHEN J
    The line starts to form for a coronavirus vaccine.
    Science. 2020;369:15-16.
    >> Share

  118. CORNWALL W
    Officials gird for a war on vaccine misinformation.
    Science. 2020;369:14-15.
    >> Share

    June 2020
  119. COHEN J
    Pandemic vaccines are about to face the real test.
    Science. 2020;368:1295-1296.
    >> Share

  120. WU NC, Thompson AJ, Lee JM, Su W, et al
    Different genetic barriers for resistance to HA stem antibodies in influenza H3 and H1 viruses.
    Science. 2020;368:1335-1340.
    >> Share

  121. CHUMAKOV K, Benn CS, Aaby P, Kottilil S, et al
    Can existing live vaccines prevent COVID-19?
    Science. 2020;368:1187-1188.
    >> Share

  122. WADMAN M
    Vaccines that use human fetal cells draw fire.
    Science. 2020;368:1170-1171.
    >> Share

  123. OGBURN EL, Bierer BE, Brookmeyer R, Choirat C, et al
    Aggregating data from COVID-19 trials.
    Science. 2020;368:1198-1199.
    >> Share

  124. BELONGIA EA, Osterholm MT
    COVID-19 and flu, a perfect storm.
    Science. 2020;368:1163.
    >> Share

    May 2020
  125. COHEN J
    Long-acting drug acts like a short-term AIDS vaccine.
    Science. 2020;368:807.
    >> Share

  126. LESLIE M
    T cells found in coronavirus patients 'bode well' for long-term immunity.
    Science. 2020;368:809-810.
    >> Share

  127. YU J, Tostanoski LH, Peter L, Mercado NB, et al
    DNA vaccine protection against SARS-CoV-2 in rhesus macaques.
    Science. 2020 May 20. pii: science.abc6284. doi: 10.1126/science.abc6284.
    >> Share

  128. COHEN J
    U.S. 'Warp Speed' vaccine effort comes out of the shadows.
    Science. 2020;368:692-693.
    >> Share

  129. WADMAN M
    Antivaccine forces gaining online.
    Science. 2020;368:699.
    >> Share

  130. SESTERHENN F, Yang C, Bonet J, Cramer JT, et al
    De novo protein design enables the precise induction of RSV-neutralizing antibodies.
    Science. 2020;368.
    >> Share

  131. COREY BL, Mascola JR, Fauci AS, Collins FS, et al
    A strategic approach to COVID-19 vaccine R&D.
    Science. 2020 May 11. pii: science.abc5312. doi: 10.1126/science.abc5312.
    >> Share

  132. KOLLMANN TR, Marchant A, Way SS
    Vaccination strategies to enhance immunity in neonates.
    Science. 2020;368:612-615.
    >> Share

  133. GRAHAM BS
    Rapid COVID-19 vaccine development.
    Science. 2020 May 8. pii: science.abb8923. doi: 10.1126/science.abb8923.
    >> Share

  134. COHEN MS, Corey L
    Combination prevention for COVID-19.
    Science. 2020;368:551.
    >> Share

  135. AZOULAY P, Jones B
    Beat COVID-19 through innovation.
    Science. 2020;368:553.
    >> Share

  136. SHAH SK, Miller FG, Darton TC, Duenas D, et al
    Ethics of controlled human infection to study COVID-19.
    Science. 2020 May 7. pii: science.abc1076. doi: 10.1126/science.abc1076.
    >> Share

  137. GAO Q, Bao L, Mao H, Wang L, et al
    Rapid development of an inactivated vaccine candidate for SARS-CoV-2.
    Science. 2020 May 6. pii: science.abc1932. doi: 10.1126/science.abc1932.
    >> Share

  138. COHEN J
    COVID-19 shot protects monkeys.
    Science. 2020;368:456-457.
    >> Share

  139. LONDON AJ, Kimmelman J
    Against pandemic research exceptionalism.
    Science. 2020;368:476-477.
    >> Share

    April 2020
  140. DONLAN AN, Petri WA Jr
    Mucosal immunity and the eradication of polio.
    Science. 2020;368:362-363.
    >> Share

  141. KAISER J
    NIH organizes hunt for drugs.
    Science. 2020;368:351.
    >> Share

  142. COHEN J
    From mice to monkeys, animals studied for coronavirus answers.
    Science. 2020;368:221-222.
    >> Share

  143. WADMAN M
    United States aims to curb vaccination injury payouts.
    Science. 2020;368:121-122.
    >> Share

  144. ROBERTS L
    Pandemic brings mass vaccinations to a halt.
    Science. 2020;368:116-117.
    >> Share

  145. ATKINSON C
    G20 leaders must answer to COVID-19.
    Science. 2020;368:111.
    >> Share

  146. COHEN J
    Infect volunteers to speed a coronavirus vaccine?
    Science. 2020;368:16.
    >> Share

  147. COHEN J
    Vaccine designers take first shots at COVID-19.
    Science. 2020;368:14-16.
    >> Share

    March 2020
  148. THORP HH
    Underpromise, overdeliver.
    Science. 2020;367:1405.
    >> Share

  149. MACKLIN GR, O'Reilly KM, Grassly NC, Edmunds WJ, et al
    Evolving epidemiology of poliovirus serotype 2 following withdrawal of the type 2 oral poliovirus vaccine.
    Science. 2020 Mar 19. pii: science.aba1238. doi: 10.1126/science.aba1238.
    >> Share

  150. THORP HH
    Do us a favor.
    Science. 2020;367:1169.
    >> Share

    February 2020
  151. HEROLD S, Sander LE
    Toward a universal flu vaccine.
    Science. 2020;367:852-853.
    >> Share

  152. WANG J, Li P, Yu Y, Fu Y, et al
    Pulmonary surfactant-biomimetic nanoparticles potentiate heterosubtypic influenza immunity.
    Science. 2020;367.
    >> Share

  153. COHEN J
    Combo of two HIV vaccines fails its big test.
    Science. 2020;367:611-612.
    >> Share

  154. GAVIER-WIDEN D, Stahl K, Dixon L
    No hasty solutions for African swine fever.
    Science. 2020;367:622-624.
    >> Share

    January 2020
  155. COHEN J
    New coronavirus threat galvanizes scientists.
    Science. 2020;367:492-493.
    >> Share

  156. STARR D
    Fighting words.
    Science. 2020;367:16-19.
    >> Share

  157. ROBERTS L
    Global polio eradication falters in the final stretch.
    Science. 2020;367:14-15.
    >> Share

  158. REINHARD K, Rengstl B, Oehm P, Michel K, et al
    An RNA vaccine drives expansion and efficacy of claudin-CAR-T cells against solid tumors.
    Science. 2020 Jan 2. pii: science.aay5967. doi: 10.1126/science.aay5967.
    >> Share

    December 2019
  159. AGAZIO A, Torres RM
    Ushering along B cells to neutralize HIV.
    Science. 2019;366:1197-1198.
    >> Share

  160. SAUNDERS KO, Wiehe K, Tian M, Acharya P, et al
    Targeted selection of HIV-specific antibody mutations by engineering B cell maturation.
    Science. 2019;366.
    >> Share

    November 2019
  161. WILDER-SMITH A, Hombach J, Cravioto A
    Misguided approach to dengue vaccine risk.
    Science. 2019;366:1082-1083.
    >> Share

  162. PULENDRAN B
    Immunology taught by vaccines.
    Science. 2019;366:1074-1075.
    >> Share

  163. KUPFERSCHMIDT K
    Top Israeli immunologist's views on vaccines trigger furor.
    Science. 2019;366:675.
    >> Share

    October 2019
  164. STEICHEN JM, Lin YC, Havenar-Daughton C, Pecetta S, et al
    A generalized HIV vaccine design strategy for priming of broadly neutralizing antibody responses.
    Science. 2019 Oct 31. pii: science.aax4380. doi: 10.1126/science.aax4380.
    >> Share

    September 2019
  165. COHEN J
    Controversy over dengue vaccine risk.
    Science. 2019;365:961-962.
    >> Share

    August 2019
  166. KUPFERSCHMIDT K
    Ebola veteran promises an end to Congo's epidemic.
    Science. 2019;365:526-527.
    >> Share

  167. CRANK MC, Ruckwardt TJ, Chen M, Morabito KM, et al
    A proof of concept for structure-based vaccine design targeting RSV in humans.
    Science. 2019;365:505-509.
    >> Share

    July 2019
  168. MA L, Dichwalkar T, Chang JYH, Cossette B, et al
    Enhanced CAR-T cell activity against solid tumors by vaccine boosting through the chimeric receptor.
    Science. 2019;365:162-168.
    >> Share

  169. ROBERTS L
    Polio eradication campaign loses ground.
    Science. 2019;365:106-107.
    >> Share

    June 2019
  170. KUPFERSCHMIDT K
    Plan to use second Ebola vaccine sparks debate.
    Science. 2019;364:1221.
    >> Share

  171. RABESANDRATANA T
    France is wary of science and vaccines, global survey finds.
    Science. 2019;364:1122.
    >> Share

    May 2019
  172. GRAHAM M, Winter AK, Ferrari M, Grenfell B, et al
    Measles and the canonical path to elimination.
    Science. 2019;364:584-587.
    >> Share

  173. GAIHA GD, Rossin EJ, Urbach J, Landeros C, et al
    Structural topology defines protective CD8(+) T cell epitopes in the HIV proteome.
    Science. 2019;364:480-484.
    >> Share

    April 2019
  174. ARKIN F
    Dengue researcher faces charges in vaccine fiasco.
    Science. 2019;364:320.
    >> Share

  175. COHEN J
    Ebola outbreak continues despite powerful vaccine.
    Science. 2019;364:223.
    >> Share

  176. COUZIN-FRANKEL J
    Lyme disease research gets a needed boost.
    Science. 2019;364:221.
    >> Share

  177. LARSON HJ, Schulz WS
    Reverse global vaccine dissent.
    Science. 2019;364:105.
    >> Share

    March 2019
  178. WADMAN M
    Vaccination opponents target CDC panel.
    Science. 2019;363:1024.
    >> Share

    February 2019
  179. REISS DR
    The law and vaccine resistance.
    Science. 2019;363:795.
    >> Share

  180. WADMAN M
    Measles epidemic in Ukraine drove troubling European year.
    Science. 2019;363:677-678.
    >> Share

  181. WILSON JT
    A sweeter approach to vaccine design.
    Science. 2019;363:584-585.
    >> Share

    December 2018
  182. TOKATLIAN T, Read BJ, Jones CA, Kulp DW, et al
    Innate immune recognition of glycans targets HIV nanoparticle immunogens to germinal centers.
    Science. 2018 Dec 20. pii: science.aat9120. doi: 10.1126/science.aat9120.
    >> Share

  183. COHEN J
    Worries about Ebola outbreak grow, despite use of vaccine.
    Science. 2018;362:1225.
    >> Share

  184. PHILLIPS MA, Goldberg DE
    Toward a chemical vaccine for malaria.
    Science. 2018;362:1112-1113.
    >> Share

  185. COHEN J
    Universal flu vaccine is 'an alchemist's dream'.
    Science. 2018;362:1094.
    >> Share

    November 2018
  186. LAURSEN NS, Friesen RHE, Zhu X, Jongeneelen M, et al
    Universal protection against influenza infection by a multidomain antibody to influenza hemagglutinin.
    Science. 2018;362:598-602.
    >> Share

    September 2018
  187. COHEN J
    Steep drop in Zika cases undermines vaccine trial.
    Science. 2018;361:1055-1056.
    >> Share

    August 2018
  188. PONS-SALORT M, Grassly NC
    Serotype-specific immunity explains the incidence of diseases caused by human enteroviruses.
    Science. 2018;361:800-803.
    >> Share

    July 2018
  189. COHEN J
    Congo rapidly curtails Ebola.
    Science. 2018;361:211-212.
    >> Share

    June 2018
  190. ABDOOL KARIM Q, Abdool Karim SS
    HIV-No time for complacency.
    Science. 2018;360:1153.
    >> Share

  191. FRIEDEN TR
    Still not ready for Ebola.
    Science. 2018;360:1049.
    >> Share

    May 2018
  192. COHEN J
    Vaccine trial launched to stop Ebola.
    Science. 2018;360:694-695.
    >> Share

    March 2018
  193. SAHIN U, Tureci O
    Personalized vaccines for cancer immunotherapy.
    Science. 2018;359:1355-1360.
    >> Share

  194. MANFREDO VIEIRA S, Hiltensperger M, Kumar V, Zegarra-Ruiz D, et al
    Translocation of a gut pathobiont drives autoimmunity in mice and humans.
    Science. 2018;359:1156-1161.
    >> Share

    February 2018
  195. KUPFERSCHMIDT K
    Use of cholera vaccines expands, raising hopes.
    Science. 2018;359:620-621.
    >> Share

    January 2018
  196. KUPFERSCHMIDT K
    Critics see only risks, no benefits in horsepox paper.
    Science. 2018;359:375-376.
    >> Share

  197. DU Y, Xin L, Shi Y, Zhang TH, et al
    Genome-wide identification of interferon-sensitive mutations enables influenza vaccine design.
    Science. 2018;359:290-296.
    >> Share

  198. PLOTKIN SA, Offit P, Begue P
    Vaccine mandates in France will save lives.
    Science. 2018;359:283-284.
    >> Share

  199. TEIJARO JR, Burton DR
    Taking down defenses to improve vaccines.
    Science. 2018;359:277-278.
    >> Share

  200. BELSER JA, Tumpey TM
    The 1918 flu, 100 years later.
    Science. 2018;359:255.
    >> Share

  201. ROBERTS L
    In Pakistan, surveillance for polio reveals a paradox.
    Science. 2018;359:142-143.
    >> Share

    December 2017
  202. NORMILE D
    Safety concerns derail dengue vaccination program.
    Science. 2017;358:1514-1515.
    >> Share

    November 2017
  203. FEINBERG MB, Ahmed R
    Advancing dengue vaccine development.
    Science. 2017;358:865-866.
    >> Share

    October 2017
  204. WARD JK, Colgrove J, Verger P
    France's risky vaccine mandates.
    Science. 2017;358:458-459.
    >> Share

  205. CHAMBERLAIN AT, Lavery JV, White A, Omer SB, et al
    Ethics of maternal vaccination.
    Science. 2017;358:452-453.
    >> Share

    September 2017
  206. COHEN J
    Why is the flu vaccine so mediocre?
    Science. 2017;357:1222-1223.
    >> Share

  207. XU L, Pegu A, Rao E, Doria-Rose N, et al
    Trispecific broadly neutralizing HIV antibodies mediate potent SHIV protection in macaques.
    Science. 2017 Sep 20. pii: eaan8630. doi: 10.1126/science.aan8630.
    >> Share

    August 2017
  208. KEAN S
    On the trail of yellow fever.
    Science. 2017;357:637-641.
    >> Share

  209. COHEN J
    Where has all the Zika gone?
    Science. 2017;357:631-632.
    >> Share

    July 2017
  210. COHEN J
    Zika rewrites maternal immunization ethics.
    Science. 2017;357:241.
    >> Share

    May 2017
  211. COHEN J
    New Ebola outbreak rings alarm bells early.
    Science. 2017;356:788-789.
    >> Share

    March 2017
  212. LESLIE M
    Can flu shots help women get pregnant?
    Science. 2017;355:1247-1248.
    >> Share

    January 2017
  213. STOKSTAD E
    Taming rabies.
    Science. 2017;355:238-242.
    >> Share

  214. COHEN J
    A half-billion-dollar bid to head off emerging diseases.
    Science. 2017;355:237.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016